Search Results

Walgreens helps raise more than $6 million for The Leukemia & Lymphoma Society (LLS) and Susan G. Komen to Advance Cancer Research and Increase Access to Care

Join us in thanking Walgreens stores and customers across the country for raising over $6 million for LLS and Susan G. Komen during their spring campaign. Donations made at checkout at more than 9,000 U.S. Walgreens locations will be split evenly between the two organizations.

During this multi-year partnership, Walgreens has helped to donate more than $25 million by 2024 to advance research for tough-to-treat cancers and increase equitable access to care.

Hairy Cell Leukemia

Hairy cell leukemia (HCL)

• Is a type of blood cancer that begins in the bone marrow
• Is a rare type of chronic leukemia 
• Hairy cell leukemia gets its name from the short, thin projections that look like hair on its cells.

What You Should Know

• Many people with hairy cell leukemia live good-quality lives for years with medical care.
• Hematologists and oncologists are specialists who treat people who have hairy cell leukemia or other types of blood cancer.
• The drug cladribine is the initial treatment for most people who h

Juvenile Myelomonocytic Leukemia

Juvenile myelomonocytic leukemia (JMML)

• Is an uncommon blood cancer that have overlapping features of two other types of blood cancers.

Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML)

• Is a cancer of the bone marrow and blood
• CML is usually diagnosed in its chronic phase when treatment is very effective for most patients
• CML has three phases

Click here to access CML statistics. 

Chronic Myelomonocytic Leukemia

Chronic myelomonocytic leukemia (CMML)

• Is an uncommon blood cancer that has features of two other types of blood cancers. For this reason, the World Health Organization (WHO) classifies CMML as myelodysplastic/myeloproliferative neoplasms. There are about 1,100 cases each year. 
• Generally affects older adults.
• Is diagnosed in twice as many males than females.

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

• Is a cancer of the bone marrow and blood
• Progresses rapidly without treatment
• Does not have a clear cause

Click here to access ALL statistics. 

Click here to access information about ALL in children and teens. 

Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) 

Acute myeloid leukemia (AML) is a cancer of the bone marrow and the blood that progresses rapidly without treatment. AML mostly affects cells that aren’t fully developed, leaving these cells unable to carry out their normal functions. It can be a difficult disease to treat; researchers are studying new approaches to AML therapy in clinical trials.

Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL)

• Is a type of blood cancer that begins in the bone marrow
• Can progress either slowly or quickly depending on the form it takes

Click here to access CLL statistics.

Leukemia Golf Classic

Booklet Updates - Leukemia

Adolescent & Young Adult Cancer Awareness Week: Free Support & Financial Resources from The Leukemia & Lymphoma Society for Blood Cancer Patients, Survivors, Families & Caregivers

** The following article highlights free resources and programs that might be of particular interest to the young adult community; these are also available to all blood cancer patients, including the families and caregivers of adolescents with a blood cancer. We encourage parents/guardians of minors (up to age 18) to request a free copy of the “Caring for Kids And Adolescents With Blood Cancer” workbook by calling 800-955-4572 and to learn more below about ways LLS can help. 

Large Granular Lymphocytic Leukemia

Large granular lymphocytic (LGL) leukemia is a type of chronic leukemia affecting white blood cells called "lymphocytes."  Lymphocytes are part of the body's immune system and help fight certain infections. LGL leukemia is characterized by enlarged lymphocytes, containing noticeable granules, which can be seen when the blood is examined under the microscope. There are two types of LGL leukemia: T-cell (T-LGL) and natural killer cell (NK-LGL). Each type may be chronic (slow-growing) or aggressive (fast-growing). 

Epigenetic Mechanisms in Acute Myeloid Leukemia

The goal of this project is to investigate the role of the epigenetic regulator Eleven-Nineteen-Leukemia (ENL) and its cancer mutations in acute myeloid leukemia (AML). Our studies leverage the expertise in chromatin biology, functional genomics, and AML modeling, as well as unique chemical compounds and mouse models. Results from this project will provide novel biological insights into our understanding of AML pathogenesis and facilitate the development of novel epigenetic therapies.

B-Cell Prolymphocytic Leukemia (B-PLL)

B-cell prolymphocytic leukemia (B-PLL) is a very rare and typically aggressive malignancy (cancer) characterized by the out of control growth of B-cells (B-lymphocytes).  B-cells are a type of white blood cell that is part of the immune system. B-PLL usually affects older adults with a median age at diagnosis of 69 years, and it is slightly more common in men than women.  Most of the time, B-PLL occurs as a transformation or evolution of a more slow-growing B-cell cancer, such as chronic lymphocytic leukemia.  Rarely, this is a primary disorder. 

T-Cell Prolymphocytic Leukemia (T-PLL)

T-cell prolymphocytic leukemia (T-PLL) is an extremely rare and typically aggressive malignancy (cancer) that is characterized by the out of control growth of mature T-cells (T-lymphocytes). T-cells are a type of white blood cell that protects the body from infections. T-PLL affects older adults with a median age at diagnosis of 61 years, and it is more common in men than in women.

Treatment of Acute Promyelocytic Leukemia

Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML). APL cells have a very specific abnormality that involves chromosomes 15 and 17, leading to the formation of an abnormal fusion gene called PML/RARα. This mutated gene causes many of the features of the disease. APL accounts for about 10-15 percent of all adult AML cases diagnosed each year. 

Resistant Chronic Myeloid Leukemia

Links For Leukemia Golf Tournament

Living with Hairy Cell Leukemia

Advances in Chronic Myeloid Leukemia